Biventricular Pacing and Defibrillator Use in Chronic Heart Failure

Cardiology Clinics

Volumn 25, Issue 4, 2007, Pages 595-603

  Cesario, David A ^a   Turner, Jonathan W ^a   Dec, G William ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CLINICAL TRIAL; DEFIBRILLATOR; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE ARRHYTHMIA; HUMAN; MONOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SUDDEN DEATH; SURVIVAL;

EID: 36549023543     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccl.2007.09.002     Document Type: Review

References (56)

1. Franciosa J.A., Limas C.J., Guiha N.H., et al. Improved left ventricular function during nitroprusside infusion in acute myocardial infarction. Lancet 1 7752 (1972) 650-654
2. Pfeffer M.A., Braunwald E., Moye L.A., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med 327 10 (1992) 669-677
3. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 10 (1999) 709-717
4. Packer M., Coats A.J., Fowler M.B., et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344 22 (2001) 1651-1658
5. Kadish A., and Mehra M. Heart failure devices: implantable cardioverter-defibrillators and biventricular pacing therapy. Circulation 111 24 (2005) 3327-3335
6. Buxton A.E., Lee K.L., Fisher J.D., et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. N Engl J Med 341 25 (1999) 1882-1890
7. Bardy G.H., Lee K.L., Mark D.B., et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 3 (2005) 225-237
8. Siebels J., Cappato R., Ruppel R., et al. Preliminary results of the Cardiac Arrest Study Hamburg (CASH). CASH Investigators. Am J Cardiol 72 16 (1993) 109F-113F
9. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 337 22 (1997) 1576-1583
10. Connolly S.J., Gent M., Roberts R.S., et al. Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone. Circulation 101 11 (2000) 1297-1302
11. Huikuri H.V., Castellanos A., and Myerburg R.J. Sudden death due to cardiac arrhythmias. N Engl J Med 345 20 (2001) 1473-1482
12. Bristow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 21 (2004) 2140-2150
13. Cleland J.G., Daubert J.C., Erdmann E., et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352 15 (2005) 1539-1549
14. Myerburg R.J., Kessler K.M., and Castellanos A. Sudden cardiac death: epidemiology, transient risk, and intervention assessment. Ann Intern Med 119 12 (1993) 1187-1197
15. Escobedo L.G., and Zack M.M. Comparison of sudden and nonsudden coronary deaths in the United States. Circulation 93 11 (1996) 2033-2036
16. Zheng Z.J., Croft J.B., Giles W.H., et al. Sudden cardiac death in the United States, 1989 to 1998. Circulation 104 18 (2001) 2158-2163
17. Baum R.S., Alvarez III H., and Cobb L.A. Survival after resuscitation from out-of-hospital ventricular fibrillation. Circulation 50 6 (1974) 1231-1235
18. Eisenberg M.S., Hallstrom A., and Bergner L. Long-term survival after out-of-hospital cardiac arrest. N Engl J Med 306 22 (1982) 1340-1343
19. Goldstein S., Landis J.R., Leighton R., et al. Predictive survival models for resuscitated victims of out-of-hospital cardiac arrest with coronary heart disease. Circulation 71 5 (1985) 873-880
20. Myerburg R.J., Kessler K.M., Estes D., et al. Long-term survival after prehospital cardiac arrest: analysis of outcome during an 8 year study. Circulation 70 4 (1984) 538-546
21. Cesario D.A., and Dec G.W. Implantable cardioverter-defibrillator therapy in clinical practice. J Am Coll Cardiol 47 8 (2006) 1507-1517
22. Gregoratos G., Abrams J., Epstein A.E., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 106 16 (2002) 2145-2161
23. Oseroff O., Retyk E., and Bochoeyer A. Subanalyses of secondary prevention implantable cardioverter-defibrillator trials: antiarrhythmics versus implantable defibrillators (AVID), Canadian Implantable Defibrillator Study (CIDS), and Cardiac Arrest Study Hamburg (CASH). Curr Opin Cardiol 19 1 (2004) 26-30
24. Priori S.G., Aliot E., Blomstrom-Lundqvist C., et al. Task Force on sudden cardiac death of the European Society of Cardiology. Eur Heart J 22 16 (2001) 1374-1450
25. Rouleau J.L., Talajic M., Sussex B., et al. Myocardial infarction patients in the 1990s-their risk factors, stratification and survival in Canada: the Canadian Assessment of Myocardial Infarction (CAMI) Study. J Am Coll Cardiol 27 5 (1996) 1119-1127
26. Moss A.J., Hall W.J., Cannon D.S., et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335 26 (1996) 1933-1940
27. Moss A.J., Zareba W., Hall W.J., et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 12 (2002) 877-883
28. Bigger Jr. J.T. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary Artery Bypass Graft (CABG) Patch Trial Investigators. N Engl J Med 337 22 (1997) 1569-1575
29. Hohnloser S.H., Kuck K.H., Dorian P., et al. Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction. N Engl J Med 351 24 (2004) 2481-2488
30. Goldenberg I., Moss A.J., McNitt S., et al. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 49 13 (2007) 1427-1433
31. Chow T., Kereiakes D.J., Bartone C., et al. Microvolt T-wave alternans identifies patients with ischemic cardiomyopathy who benefit from implantable cardioverter-defibrillator therapy. J Am Coll Cardiol 49 1 (2007) 50-58
32. Bansch D., Antz M., Boczor S., et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: the Cardiomyopathy Trial (CAT). Circulation 105 12 (2002) 1453-1458
33. Strickberger S.A., Hummel J.D., Bartlett T.G., et al. Amiodarone versus implantable cardioverter-defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 41 10 (2003) 1707-1712
34. Fonarow G.C., Feliciano Z., Boyle N.G., et al. Improved survival in patients with nonischemic advanced heart failure and syncope treated with an implantable cardioverter-defibrillator. Am J Cardiol 85 8 (2000) 981-985
35. Knight B.P., Goyal R., Pelosi F., et al. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator. J Am Coll Cardiol 33 7 (1999) 1964-1970
36. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 21 (2004) 2151-2158
37. Kadish A., Schaechter A., Subacius H., et al. Patients with recently diagnosed nonischemic cardiomyopathy benefit from implantable cardioverter-defibrillators. J Am Coll Cardiol 47 12 (2006) 2477-2482
38. Burkhardt J.D., and Wilkoff B.L. Interventional electrophysiology and cardiac resynchronization therapy: delivering electrical therapies for heart failure. Circulation 115 16 (2007) 2208-2220
39. Baldasseroni S., Opasich C., Gorini M., et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J 143 3 (2002) 398-405
40. Aaronson K.D., Schwartz J.S., Chen T.M., et al. Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation. Circulation 95 12 (1997) 2660-2667
41. Shamim W., Francis D.P., Yousufuddin M., et al. Intraventricular conduction delay: a prognostic marker in chronic heart failure. Int J Cardiol 70 2 (1999) 171-178
42. Bax J.J., Bleeker G.B., Marwick T.H., et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol 44 9 (2004) 1834-1840
43. Breithardt O.A., and Breithardt G. Quest for the best candidate: how much imaging do we need before prescribing cardiac resynchronization therapy?. Circulation 113 7 (2006) 926-928
44. Suffoletto M.S., Dohi K., Cannesson M., et al. Novel speckle-tracking radial strain from routine black-and-white echocardiographic images to quantify dyssynchrony and predict response to cardiac resynchronization therapy. Circulation 113 7 (2006) 960-968
45. Heart Failure Society Of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail 12 1 (2006) E1-E2
46. Cazeau S., Leclercq C., Lavergne T., et al. Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay. N Engl J Med 344 12 (2001) 873-880
47. Abraham W.T., Fisher W.G., Smith A.L., et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 346 24 (2002) 1845-1853
48. Gras D., Leclercq C., Tang A.S., et al. Cardiac resynchronization therapy in advanced heart failure the multicenter InSync clinical study. Eur J Heart Fail 4 3 (2002) 311-320
49. Lindenfeld J., Feldman A.M., Saxon L., et al. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure. Circulation 115 2 (2007) 204-212
50. Strickberger S.A., Conti J., Daoud E.G., et al. Patient selection for cardiac resynchronization therapy: from the Council on Clinical Cardiology Subcommittee on Electrocardiography and Arrhythmias and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society. Circulation 111 16 (2005) 2146-2150
51. Abraham W.T. Cardiac resynchronization therapy is important for all patients with congestive heart failure and ventricular dyssynchrony. Circulation 114 24 (2006) 2692-2698 [discussion: 2698]
52. Bleeker G.B., Holman E.R., Steendijk P., et al. Cardiac resynchronization therapy in patients with a narrow QRS complex. J Am Coll Cardiol 48 11 (2006) 2243-2250
53. Yu C.M., Chan Y.S., Zhang Q., et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol 48 11 (2006) 2251-2257
54. Delnoy P.P., Ottervanger J.P., Luttikhuis H.O., et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol 99 9 (2007) 1252-1257
55. Wilkoff B.L., Cook J.R., Epstein A.E., et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA 288 24 (2002) 3115-3123
56. Sweeney M.O., Ruskin J.N., Garan H., et al. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation. Circulation 92 11 (1995) 3273-3281